Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics COGT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Cogent Biosciences Inc

COGT
Current price
10.98 USD +0.13 USD (+1.20%)
Last closed 10.85 USD
ISIN US19240Q2012
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 578 067 456 USD
Yield for 12 month +18.70 %
1Y
3Y
5Y
10Y
15Y
COGT
21.11.2021 - 28.11.2021

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts. Address: 275 Wyman Street, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.20 USD

P/E Ratio

Dividend Yield

Financials COGT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-3 588 000 USD

Current Quarter

Last Quarter

EBITDA -285 976 992 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -47.45 %
PEG Ratio
Return On Equity TTM -84.04 %
Wall Street Target Price 16.20 USD
Revenue TTM
Book Value 0.97 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM -121 627 000 USD
Earnings per share -1.97 USD
Diluted Eps TTM -1.97 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation COGT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 925.41
Price Sales TTM 1 320.63
Enterprise Value EBITDA -3.89
Price Book MRQ 10.68

Technical Indicators COGT

For 52 Weeks

3.72 USD 12.61 USD
50 Day MA 6.36 USD
Shares Short Prior Month 16 522 675
200 Day MA 7.95 USD
Short Ratio 9.55
Shares Short 12 402 337
Short Percent 16.99 %